Ongoing Clinical Trials
 | Global SUMOylation by Ubc9 Overexpression Protects Mouse Brain Against Focal Cerebral Ischemic Damage |
| CONSCIOUS-2 Effect of Clazosentan on Clinical Outcome After Aneurysmal Subarachnoid Hemorrhage and Surgical Clipping: Results of the CONSCIOUS-2 Study |
| SCAST Angiotensin Receptor Blockade In Acute Stroke: Results From The Scandinavian Candesartan Acute Stroke Trial (SCAST), A Double-blind, Randomized- And Placebo-controlled Trial |
| LEAPS Locomotor Experience Applied Post-stroke (LEAPS): A Randomized Controlled Trial |
| Intracranial Angioplasty and/or Stent Placement in General Practice. An Analysis of 370,061 Patient Admissions with Ischemic Stroke |
Late-Breaking Abstracts
| A Small Molecule Brain-Derived Neurotrophic Factor Mimetic, Administered Beginning Three Days After Stroke, Improves Functional Recovery |
| Results of the Carotid Occlusion Surgery Study (COSS) |
| The Albumin in Acute Stroke (ALIAS) Part 1 Trial: An exploratory efficacy analysis |
| Upper Extremity Robotic Therapy is Effective in Post-stroke Hemiplegia: a Randomized Controlled Trial |
| Interventional Acute Stroke Therapy with the Merci Retriever Embolectomy Device: Results from 1000 patients in a Open Label Prospective Multicenter Registry |
| Stroke Sequelae Among Elderly Population: The Health and Retirement Study 1998-2008 |
| Flame: A Multicenter Randomized Double-blind Placebo-controlled Trial With Fluoxetine In Motor Recovery Of Patients With Acute Ischaemic Stroke. |
